Rosuvastatin vs Simvastatin

Rosuvastatin is the most potent statin available. At its starting dose of 10 mg, rosuvastatin reduces LDL-C by approximately 46%, compared to about 30% for simvastatin 10 mg. At maximum dose, rosuvastatin 40 mg can lower LDL-C by roughly 55-63%.

The STELLAR trial demonstrated that rosuvastatin achieved significantly greater LDL-C reductions than simvastatin, atorvastatin, and pravastatin across all dose comparisons. The JUPITER trial further showed that rosuvastatin 20 mg significantly reduced cardiovascular events in patients with elevated C-reactive protein but normal LDL-C levels.

Simvastatin has its own landmark evidence from the 4S trial, demonstrating a 30% reduction in overall mortality in patients with coronary heart disease. Both drugs effectively reduce cardiovascular events when used at appropriate doses.

Both drugs share the typical statin side effect profile: muscle pain, elevated liver enzymes, headache, and gastrointestinal symptoms. Overall tolerability is similar at equivalent therapeutic doses.

Simvastatin carries specific safety concerns at its highest dose (80 mg), where the FDA has warned of increased myopathy and rhabdomyolysis risk. Simvastatin 80 mg should not be initiated in new patients. Rosuvastatin does not have a comparable dose-specific restriction, though doses above 20 mg are used with caution in certain populations.

Rosuvastatin is minimally metabolized by CYP enzymes and therefore has significantly fewer drug interactions than simvastatin. Simvastatin's extensive CYP3A4 metabolism creates interactions with medications including amiodarone, amlodipine, diltiazem, and certain antibiotics and antifungals.

Both rosuvastatin and simvastatin are available as generics. Simvastatin generics have been available since 2006, while rosuvastatin became generic in 2016. Both typically cost $4-$20 for a 30-day supply.

Simvastatin may be marginally cheaper at some pharmacies due to its longer generic availability, but both are included in most $4 generic drug programs. Cost differences are minimal and unlikely to drive prescribing decisions.

Both are taken once daily as oral tablets. Simvastatin should be taken in the evening due to its short half-life (2-3 hours), while rosuvastatin has a longer half-life (approximately 19 hours) and can be taken at any time of day.

Rosuvastatin does not need to be taken with food. The dosing flexibility of rosuvastatin may improve medication adherence for patients who prefer morning dosing.

Rosuvastatin is generally preferred when maximal LDL lowering is needed, when a patient takes medications that interact with CYP3A4, or when dosing flexibility is important. Simvastatin remains appropriate for patients requiring moderate LDL reduction who tolerate it well, particularly at doses of 20-40 mg.

If you are currently on simvastatin and your LDL goals are not being met, your healthcare provider may consider switching to rosuvastatin for greater efficacy. Always consult your healthcare provider before making changes to your statin therapy.